Evaluation of Serum Lipid Associated Sialic Acid (LASA) Concentration, Malonaldehyde Determination and Some Biochemical Parameters in Arteriosclerosis Patients.
Keywords:
Lipid associated sialic acid, Atherosclerosis disease, LFTAbstract
The present study was carried out to evaluate the level Lipid associated Sialic Acid (LASA) in patients with cardiovascular Atherosclerosis disease. The study includes three groups the first those who conducted the operation of heart catheter, the second who prepared to enter for catheterizing operation they didn't conducted Catheter operations for them before, while the last group are the normal persons control. The data analysis reflects a significant increase serum LASA level in the patients when compared to normal controls (P< 0.0001) for the both patients groups which were done operation catheterize and those are prepared to enter the catheterize. As will as there were shows high significant coloration relation of LASA with some biochemical parameter such as (Bilirubin, HbA1C, thyroxine T4 and CK-MB).
References
Chappey B., Beyssen B., Foos E., Sialic acid content of LDL in coronary artery disease. Arterioscler Thromb Vasc Biol.1998:18(6): 876-883.
Citll M., Gunes., et al. Evaluation of serum sialic acid as an inflammation marker in cattle with traumatic reticuloperitonitis Revue Med. 2004, 155, 7, 389-392.
Crooke M., Tutt P., Pickup J. C. Elevation serum sialic acid concentrations in NIDDM and its relation to blood pressurand retinopathy. Diabetes care.1993,16: 57-60.[28]-
Dutt M., Chatterjee J.M., Khanade J.M.,Rajan S.R., glycoproteins in patients of ischemic heart disese and normalcontrols. Ind J Med Res.1975, 63:2: 282-285.
Gabrlel L, Ekeke O. analysis of glycoprotein .J.Clin.Chem. 1988,347:1443-1446.
Gokmen S.S., Kilichi G., OZ Celik F., Gulen S., Serum total and lipid-bound sialic acid levels following acute myocardial infarction.Clin Chem Lab Med, 38(12): 1249-1255,(2000)
Haq, M., Haq, S., et al. serum total sialic and lipid-associated serum sialic in normal individual patients with myocardial infarction and their relationship to acute phase proteins. Ann.Clin. Bioche.1993, 30: 383-386
Katopodis N, Stock C C. Improved method to determine lipids bound sialic acid in plasma or serum. Res. Comm. Chem-patho-Pharmacol. 1980;30:171-180.
Lindberg G, Iso H, Rastam L, et al. Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis. USA. International. Journal of Epidemiology. 1997;26(1):58-63.
Lindberg G., Rastam L., Gullberg B.,Eklund G.A., Tornberg S., Serum sialic acid concentration and smoking : a population based study. BMJ, 303: 1306-1307,(1991)
Maritta P nni , Hannu Alho,Seppo T. Nikkari , Uif Olsson , Uif R ydberg and
Merat A ., Arabsolghar R., Zamani J. Serum levels of sialic acid and neuraminidase activity in cardiovascular, diabetic and diabetic retinopathy patients. Iran J Med Sci. 2003,28(3):123-126,
Nonda K., Yashar H., Nancy L.,et al. Lipid- associated sialic acid test for the detection of human cancer , Cancer Res.1982,42;5270-5275.
Nopnda K, Yashar H, Nancy L, et al. Lipid- associated sialic acid for detection of human cancer. Cancer. Res. 1982;42:5270-5275.
Okude M., Yamanaka A., Akihama S. The effect of pH on the generation of turbidity and elasticity associated with fibrinogen fibrin conversion by thrombinand remarkable by influenced by sialic acid in fibrinogen by thrombin and remarkable by influenced by sialic acid in fibrinogen. Bio-Pharm-Bull.1995, 18(2): 203-207.
Pekka Sillanaukee . Serum Sialic Acid in a Random Sample of the General
Population,ClinicalChemistry.1999,45:1842-1849.
Robert R M, Peter A M, Drayl K G, et al. Carbohydrate of significant physiological. Harper’s Biochemistry, 22nd ed. 1993; 130-139.
Shivanada Nayak and Loslely Roberts; Relationship between inflammatory marker, metabolic and anthropometric variables in the caribean type 2 diabetic patients with and without microvascular complications. Journal of Inflammation.2006, 3:17-27.
Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest.1999: 29 (5): 413-425,
Sillanaukee P, Pönniö M, Jääskeläinen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Investig 1999;29:413-425.
Suer G. S., Kazwzoglu C.Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive nproteins and cell damage in patients with acute myocardial infarction. Clin. Chem.Lab. Med.2006,44 (2) : 199-206.
Svennerholm L. Determination of sialic acid. Biochem- Biophys. Acta. 1957;234:1971-1975.
Weinstein, T., Avry C., Asher K., Mona B., Yaacov O., Michal H., Tsipora M., and Uzi G.. Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial transplant; 2000, 15:883-887.
Weinstein, T., Avry C., Asher K., Mona B., Yaacov O., Michal H., Tsipora M., and Uzi G. Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial transplant.2000,15:883-887.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work, with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online.